Here is the 10 reason why should MLXO worth 0.15 - 0.20

1.MLXO HAS ACQUIRED 100% OF THE OUTSTANDING SHARES OF PRISTINE PHARMA CORPORATION, A PHARMACEUTICAL MANUFACTURING AND DISTRIBUTION COMPANY THAT SELLS BOTH PRIVATE LABEL AND ITS OWN NUMED BRAND LABEL PHARMACEUTICALS. THE MANAGEMENT OF PRISTINE PHARMA IS VERY WELL EXPERIENCED IN EXPORT OF PHARMACEUTICAL DRUGS FROM USA AND ARE WELL REGARDED BY BOTH US DEPARTMENT OF COMMERCE AND NJ ECONOMIC DEVELOPMENT AUTHORITY FOR THEIR EXPERTISE IN EXPORTING US MADE PRODUCTS.

2. MLXO announced that its wholly owned subsidiary, Pristine Pharma Corporation, has started deliveries of OTC pharmaceutical products to its customers who are export distributors. These products are currently contract manufactured at FDA registered pharmaceutical plants in New Jersey and New York.

3.MLXO has started moving the pharmaceutical manufacturing assets of Pristine Pharma Corporation to its own facility in the State of New York. The facility, lease-purchased by Pristine Pharma, where all the lease payments will be applied towards the purchase price, is comprised of 32,000 sq ft including approximately 4.2 acres of land in an industrial zone.

4.Pristine Pharma sells Over The Counter pharmaceutical products in store brand, private label and in its own control label, ‘NUMED.’ Pristine Pharma is holding purchase orders for its line of OTC pharmaceutical products, worth over $2.8 million from its domestic customers, as well as export distributors.

5.Pristine sells Over The Counter pharmaceutical products in store brand, private label and its own control label, 'NUMED.' United has invested $1 million of working capital into Pristine, while another $3.5 million funding in the form of a convertible note was provided by a boutique hedge fund based in New York for the acquisition of manufacturing assets -- equipment, formulations and inventory. ASSET $13 000 000 including all

6.MLXO announced that it has acquired all of the issued and outstanding shares of United Mortgage Bankers, Ltd. d/b/a United Merchant Bankers, ("United") a financial services company in Stamford, CT. As a result of the acquisition, United became a subsidiary of Michelex.

7.MLXO new CEO Mr. Laclé stated that, "I am very confident that with over 100 years of combined experience of the executives who are now sharing the responsibilities with me to develop Michelex as a viable entity, I believe we will prove worthy of shareholders' expectations.

8.MLXO PRISTINE PHARMA CORPORATION, A SUBSIDIARY OF MICHELEX, OBTAINED PURCHASE ORDERS FOR ITS NUMED BRAND PHARMACEUTICALS FROM DOMESTIC DISTRIBUTORS WORTH OVER $1.8 MILLION.

9. MLXO going to announce production, distribution (nationwide and world wide),sells contract( possible with major pharmaceutical stores) partners, revenue ( already received $1.8m worth order)next several weeks. MLXO has nearly 100 different kind of Pharmaceutical Drugs patent and FDA approval.

Check out products: http://pristinepharmacorp.com/html/index.aspx?page=viewproducts

10. NO REVERSE SPLIT DISCUSSED, PER Investor Relations.
Most of float in strong long term investors hand even a lot people own shares from $1.00 to here, noticed the stock broke out major resistance 0.005 area with only 6m volume, Japanese trading group announced price target between 0.15 -0.20 most of share holders and our members achieving to get there and locked all our shares higher levels mostly up to 0.10

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=56020115&txt2find=mlxo